In the present study, the patients who received SGLT-2 inhibitors for T2DM and had concomitant CAD reported a numerically higher incidence of genital infections as compared to those without CAD but the difference was not statistically significant (p=0.712). Here, SLC5A2 is linked to coronary artery disorder.